I, D., & D, G. (2026). Leveraging Mendelian randomization to inform drug discovery and development for ischemic stroke. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 46(6), 1404. https://doi.org/10.1177/0271678X241305916
Chicago Style (17th ed.) CitationI, Daghlas, and Gill D. "Leveraging Mendelian Randomization to Inform Drug Discovery and Development for Ischemic Stroke." Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism 46, no. 6 (2026): 1404. https://doi.org/10.1177/0271678X241305916.
MLA (9th ed.) CitationI, Daghlas, and Gill D. "Leveraging Mendelian Randomization to Inform Drug Discovery and Development for Ischemic Stroke." Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism, vol. 46, no. 6, 2026, p. 1404, https://doi.org/10.1177/0271678X241305916.